Showing 1–7 of 7 results for author: Adibuzzaman, M

Environment Scan of Generative AI Infrastructure for Clinical and Translational Science

Authors: Betina Idnay, Zihan Xu, William G. Adams, Mohammad Adibuzzaman, Nicholas R. Anderson, Neil Bahroos, Douglas S. Bell, Cody Bumgardner, Thomas Campion, Mario Castro, James J. Cimino, I. Glenn Cohen, David Dorr, Peter L Elkin, Jungwei W. Fan, Todd Ferris, David J. Foran, David Hanauer, Mike Hogarth, Kun Huang, Jayashree Kalpathy-Cramer, Manoj Kandpal, Niranjan S. Karnik, Avnish Katoch, Albert M. Lai , et al. (32 additional authors not shown)

Abstract: This study reports a comprehensive environmental scan of the generative AI (GenAI) infrastructure in the national network for clinical and translational science across 36 institutions supported by the Clinical and Translational Science Award (CTSA) Program led by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) at the United States. With t… ▽ More This study reports a comprehensive environmental scan of the generative AI (GenAI) infrastructure in the national network for clinical and translational science across 36 institutions supported by the Clinical and Translational Science Award (CTSA) Program led by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) at the United States. With the rapid advancement of GenAI technologies, including large language models (LLMs), healthcare institutions face unprecedented opportunities and challenges. This research explores the current status of GenAI integration, focusing on stakeholder roles, governance structures, and ethical considerations by administering a survey among leaders of health institutions (i.e., representing academic medical centers and health systems) to assess the institutional readiness and approach towards GenAI adoption. Key findings indicate a diverse range of institutional strategies, with most organizations in the experimental phase of GenAI deployment. The study highlights significant variations in governance models, with a strong preference for centralized decision-making but notable gaps in workforce training and ethical oversight. Moreover, the results underscore the need for a more coordinated approach to GenAI governance, emphasizing collaboration among senior leaders, clinicians, information technology staff, and researchers. Our analysis also reveals concerns regarding GenAI bias, data security, and stakeholder trust, which must be addressed to ensure the ethical and effective implementation of GenAI technologies. This study offers valuable insights into the challenges and opportunities of GenAI integration in healthcare, providing a roadmap for institutions aiming to leverage GenAI for improved quality of care and operational efficiency. △ Less

Submitted 27 September, 2024; originally announced October 2024.

Causal Discovery on the Effect of Antipsychotic Drugs on Delirium Patients in the ICU using Large EHR Dataset

Authors: Riddhiman Adib, Md Osman Gani, Sheikh Iqbal Ahamed, Mohammad Adibuzzaman

Abstract: Delirium occurs in about 80% cases in the Intensive Care Unit (ICU) and is associated with a longer hospital stay, increased mortality and other related issues. Delirium does not have any biomarker-based diagnosis and is commonly treated with antipsychotic drugs (APD). However, multiple studies have shown controversy over the efficacy or safety of APD in treating delirium. Since randomized control… ▽ More Delirium occurs in about 80% cases in the Intensive Care Unit (ICU) and is associated with a longer hospital stay, increased mortality and other related issues. Delirium does not have any biomarker-based diagnosis and is commonly treated with antipsychotic drugs (APD). However, multiple studies have shown controversy over the efficacy or safety of APD in treating delirium. Since randomized controlled trials (RCT) are costly and time-expensive, we aim to approach the research question of the efficacy of APD in the treatment of delirium using retrospective cohort analysis. We plan to use the Causal inference framework to look for the underlying causal structure model, leveraging the availability of large observational data on ICU patients. To explore safety outcomes associated with APD, we aim to build a causal model for delirium in the ICU using large observational data sets connecting various covariates correlated with delirium. We utilized the MIMIC III database, an extensive electronic health records (EHR) dataset with 53,423 distinct hospital admissions. Our null hypothesis is: there is no significant difference in outcomes for delirium patients under different drug-group in the ICU. Through our exploratory, machine learning based and causal analysis, we had findings such as: mean length-of-stay and max length-of-stay is higher for patients in Haloperidol drug group, and haloperidol group has a higher rate of death in a year compared to other two-groups. Our generated causal model explicitly shows the functional relationships between different covariates. For future work, we plan to do time-varying analysis on the dataset. △ Less

Submitted 28 April, 2022; originally announced May 2022.

Pragmatic Clinical Trials in the Rubric of Structural Causal Models

Authors: Riddhiman Adib, Sheikh Iqbal Ahamed, Mohammad Adibuzzaman

Abstract: Explanatory studies, such as randomized controlled trials, are targeted to extract the true causal effect of interventions on outcomes and are by design adjusted for covariates through randomization. On the contrary, observational studies are a representation of events that occurred without intervention. Both can be illustrated using the Structural Causal Model (SCM), and do-calculus can be employ… ▽ More Explanatory studies, such as randomized controlled trials, are targeted to extract the true causal effect of interventions on outcomes and are by design adjusted for covariates through randomization. On the contrary, observational studies are a representation of events that occurred without intervention. Both can be illustrated using the Structural Causal Model (SCM), and do-calculus can be employed to estimate the causal effects. Pragmatic clinical trials (PCT) fall between these two ends of the trial design spectra and are thus hard to define. Due to its pragmatic nature, no standardized representation of PCT through SCM has been yet established. In this paper, we approach this problem by proposing a generalized representation of PCT under the rubric of structural causal models (SCM). We discuss different analysis techniques commonly employed in PCT using the proposed graphical model, such as intention-to-treat, as-treated, and per-protocol analysis. To show the application of our proposed approach, we leverage an experimental dataset from a pragmatic clinical trial. Our proposition of SCM through PCT creates a pathway to leveraging do-calculus and related mathematical operations on clinical datasets. △ Less

Submitted 28 April, 2022; originally announced April 2022.

CKH: Causal Knowledge Hierarchy for Estimating Structural Causal Models from Data and Priors

Authors: Riddhiman Adib, Md Mobasshir Arshed Naved, Chih-Hao Fang, Md Osman Gani, Ananth Grama, Paul Griffin, Sheikh Iqbal Ahamed, Mohammad Adibuzzaman

Abstract: Structural causal models (SCMs) provide a principled approach to identifying causation from observational and experimental data in disciplines ranging from economics to medicine. However, SCMs, which is typically represented as graphical models, cannot rely only on data, rather require support of domain knowledge. A key challenge in this context is the absence of a methodological framework for enc… ▽ More Structural causal models (SCMs) provide a principled approach to identifying causation from observational and experimental data in disciplines ranging from economics to medicine. However, SCMs, which is typically represented as graphical models, cannot rely only on data, rather require support of domain knowledge. A key challenge in this context is the absence of a methodological framework for encoding priors (background knowledge) into causal models in a systematic manner. We propose an abstraction called causal knowledge hierarchy (CKH) for encoding priors into causal models. Our approach is based on the foundation of "levels of evidence" in medicine, with a focus on confidence in causal information. Using CKH, we present a methodological framework for encoding causal priors from various information sources and combining them to derive an SCM. We evaluate our approach on a simulated dataset and demonstrate overall performance compared to the ground truth causal model with sensitivity analysis. △ Less

Submitted 1 September, 2022; v1 submitted 28 April, 2022; originally announced April 2022.

Structural Causal Model with Expert Augmented Knowledge to Estimate the Effect of Oxygen Therapy on Mortality in the ICU

Authors: Md Osman Gani, Shravan Kethireddy, Marvi Bikak, Paul Griffin, Mohammad Adibuzzaman

Abstract: Recent advances in causal inference techniques, more specifically, in the theory of structural causal models, provide the framework for identification of causal effects from observational data in the cases where the causal graph is identifiable, i.e., the data generating mechanism can be recovered from the joint distribution. However, no such studies have been done to demonstrate this concept with… ▽ More Recent advances in causal inference techniques, more specifically, in the theory of structural causal models, provide the framework for identification of causal effects from observational data in the cases where the causal graph is identifiable, i.e., the data generating mechanism can be recovered from the joint distribution. However, no such studies have been done to demonstrate this concept with a clinical example. We present a complete framework to estimate the causal effect from observational data by augmenting expert knowledge in the model development phase and with a practical clinical application. Our clinical application entails a timely and important research question, i.e., the effect of oxygen therapy intervention in the intensive care unit (ICU); the result of this project is useful in a variety of disease conditions, including severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) patients in the ICU. We used data from the MIMIC III database, a standard database in the machine learning community that contains 58,976 admissions from an ICU in Boston, MA, for estimating the oxygen therapy effect on morality. We also identified the covariate-specific effect to oxygen therapy from the model for more personalized intervention. △ Less

Submitted 28 October, 2020; originally announced October 2020.

Collaborative Cloud Computing Framework for Health Data with Open Source Technologies

Authors: Fatemeh Rouzbeh, Ananth Grama, Paul Griffin, Mohammad Adibuzzaman

Abstract: The proliferation of sensor technologies and advancements in data collection methods have enabled the accumulation of very large amounts of data. Increasingly, these datasets are considered for scientific research. However, the design of the system architecture to achieve high performance in terms of parallelization, query processing time, aggregation of heterogeneous data types (e.g., time series… ▽ More The proliferation of sensor technologies and advancements in data collection methods have enabled the accumulation of very large amounts of data. Increasingly, these datasets are considered for scientific research. However, the design of the system architecture to achieve high performance in terms of parallelization, query processing time, aggregation of heterogeneous data types (e.g., time series, images, structured data, among others), and difficulty in reproducing scientific research remain a major challenge. This is specifically true for health sciences research, where the systems must be i) easy to use with the flexibility to manipulate data at the most granular level, ii) agnostic of programming language kernel, iii) scalable, and iv) compliant with the HIPAA privacy law. In this paper, we review the existing literature for such big data systems for scientific research in health sciences and identify the gaps of the current system landscape. We propose a novel architecture for software-hardware-data ecosystem using open source technologies such as Apache Hadoop, Kubernetes and JupyterHub in a distributed environment. We also evaluate the system using a large clinical data set of 69M patients. △ Less

Submitted 20 July, 2020; originally announced July 2020.

Comments: This paper is accepted in ACM-BCB 2020

A Causally Formulated Hazard Ratio Estimation through Backdoor Adjustment on Structural Causal Model

Authors: Riddhiman Adib, Paul Griffin, Sheikh Iqbal Ahamed, Mohammad Adibuzzaman

Abstract: Identifying causal relationships for a treatment intervention is a fundamental problem in health sciences. Randomized controlled trials (RCTs) are considered the gold standard for identifying causal relationships. However, recent advancements in the theory of causal inference based on the foundations of structural causal models (SCMs) have allowed the identification of causal relationships from ob… ▽ More Identifying causal relationships for a treatment intervention is a fundamental problem in health sciences. Randomized controlled trials (RCTs) are considered the gold standard for identifying causal relationships. However, recent advancements in the theory of causal inference based on the foundations of structural causal models (SCMs) have allowed the identification of causal relationships from observational data, under certain assumptions. Survival analysis provides standard measures, such as the hazard ratio, to quantify the effects of an intervention. While hazard ratios are widely used in clinical and epidemiological studies for RCTs, a principled approach does not exist to compute hazard ratios for observational studies with SCMs. In this work, we review existing approaches to compute hazard ratios as well as their causal interpretation, if it exists. We also propose a novel approach to compute hazard ratios from observational studies using backdoor adjustment through SCMs and do-calculus. Finally, we evaluate the approach using experimental data for Ewing's sarcoma. △ Less

Submitted 22 June, 2020; originally announced June 2020.

Comments: 19 pages, Accepted at Machine Learning for Healthcare 2020

ACM Class: G.3; I.2.3